Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease

Blood

Volumn 119, Issue 24, 2012, Pages 5671-5673

  Fitzhugh, Courtney D ^d   Unno, Hayato ^a   Hathaway, Vincent ^a   Coles, Wynona A ^a   Link, Mary E ^a   Weitzel, R Patrick ^a   Zhao, Xiongce ^b   Wright, Elizabeth C ^c   Stroncek, David F ^a   Kato, Gregory J ^a   Hsieh, Matthew M ^a   Tisdale, John F ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Office of the Director   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIMETHYL SULFOXIDE; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; SODIUM CHLORIDE;

ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; HEART CONTRACTION; HEMOLYSIS; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN SECRETION; SICKLE CELL ANEMIA; TRICUSPID REGURGITANT VELOCITY; TRICUSPID VALVE;

EID: 84862486952     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-392654     Document Type: Article

References (19)

1. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant. 1990;5 (Suppl) 1:25-27.
2. Alessandrino P, Bernasconi P, Caldera D, et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant. 1999;23(6):533-537. (Pubitemid 29137440)
3. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood. 1990;75(3):781-786. (Pubitemid 20069222)
4. Styler MJ, Topolsky DL, Crilley PA, et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant. 1992;10(5):435-438.
5. Keung YK, Lau S, Elkayam U, Chen SC, Douer D. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant. 1994;14(3):363-367. (Pubitemid 24295226)
6. Zenhäusern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol. 2000;79(9):523-526.
7. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant. 2004;10(2):135-141. (Pubitemid 38145867)
8. Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ. Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant. 1991;7(5):401-403.
9. Hameroff SR, Otto CW, Kanel J, Weinstein PR, Blitt CD. Acute cardiovascular effects of dimethyl sulfoxide. Ann N Y Acad Sci. 1983;411:94-99. (Pubitemid 13072006)
10. Rowley SD, Feng Z, Yadock D, Holmberg L, Macleod B, Heimfeld S. Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade. Cytotherapy. 1999;1(6):439-446.
11. Shlafer M, Matheny JL, Karow AM Jr. Cardiac chronotropic mechanisms of dimethyl sulphoxide: inhibition of acetylcholinesterase and antagonism of negative chronotropy by atropine. Arch Int Pharmacodyn Ther. 1976;221(1):21-31.
12. Shlafer M. Cardiac pharmacology of dimethyl sulfoxide and its postulated relevance to organ preservation in ischemic or hypoxic states. Ann N Y Acad Sci. 1983;411:170-179. (Pubitemid 13072016)
13. Clifford DH, Lee DC, Lee MO. Effects of dimethyl sulfoxide and acupuncture on the cardiovascular system of dogs. Ann N Y Acad Sci. 1983;411:84-93. (Pubitemid 13072005)
14. Winslow RM. Red cell substitutes. Semin Hematol. 2007;44(1):51-59. (Pubitemid 46019827)
15. Amberson WR, Jennings JJ, Rhode CM. Clinical experience with hemoglobin-saline solutions. J Appl Physiol. 1949;1(7):469-489.
16. Savitsky JP, Doczi J, Black J, Arnold JD. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther. 1978;23(1):73-80. (Pubitemid 8290413)
17. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8(12):1383-1389. (Pubitemid 36019423)
18. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653-1662. (Pubitemid 40471796)
19. Waugh W, Daeschner CW, Files BA, Gordon DW. Evidence that L-arginine is a key amino acid in sickle cell anemia: a preliminary report. Nutrition Res. 1999;19(4):501-518. (Pubitemid 29205534)